In HCC and CRLM higher percent of (M)-MDSCs (CD14+HLA−DRlow/−CD15−) was observed as compared to HD, while only in HCC (PMN)-MDSCs (CD11b+CD15+CD33+Lin−HLA-DRlow/−) were highly represented. The gene discussed is CD33; the disease is hepatocellular carcinoma.